Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects

Clinical trial NCT00673387 · COMPLETED

Trial details

NCT number: NCT00673387
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2008-04-01
Primary completion: 2009-04-01
Enrollment: 636

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.